TNF Pharmaceuticals (TNFA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TNFA TNF Pharmaceuticals

Watchlist

1.196
-0.034-2.75%

Close Nov 15 16:00 ET

1.160
-0.036-2.98%

Post 20:01 ET

3.29MMarket Cap-88P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TNF Pharmaceuticals | 10-Q: Quarterly report
SECNov 14 17:08 ET · Announcements
Eagle EGRX Delist; TNF Pharmaceuticals TNFA Equity Investment
BioPharmCatalystOct 2 14:01 ET
Express News | Tnf Pharmaceuticals Inc - Fully Funded for Clinical Trials for Next Two Years
ReutersOct 2 09:10 ET
TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
BusinesswireOct 2 09:10 ET
Express News | Tnf Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
ReutersOct 2 09:10 ET
Top Premarket Decliners
MT NewswiresSep 26 08:04 ET

Comments

Trytosaveabit

Oct 2 08:11

Update

$TNF Pharmaceuticals (TNFA.US)$ TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
1 MINUTE AGO, 9:10 AM EDT
VIA BUSINESSWIRE
Prevail Partners, LLC investment priced at more than a 40% premium to market
Prevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service CRO with hundreds of clinical trials over a decade
TNF Pharmaceuticals fully funded for clinical trials for next two years